This week on Contemporary OB/GYN®: August 16 to August 20

Article

Here's what to look for this week on Contemporary OB/GYN®.

You can expect a variety of topics this week, including:

FDA accepts pembrolizumab as singlea agent for treatment of advanded endometrial cancer

New biomarker could predict immunotherapy benefit in breast cancer

New Hampshire's abortion restrictions

Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome

The impact of nutrition on gynecological diseases

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
© 2024 MJH Life Sciences

All rights reserved.